Description

Methylprednisolone is a synthetic glucocorticoid with potent anti?inflammatory and immunosuppressive properties. These tablets are used in scientific research to evaluate corticosteroid-mediated pathways, immune modulation, and metabolic regulation.

This 16?mg tablet formulation from Zhejiang Xianju Pharmaceutical Co., Ltd. is ideal for in vitro and in vivo laboratory applications targeting models of rheumatoid arthritis, autoimmune disorders, endocrinology, and acute inflammation. Manufactured under approval number H20213809 and product code 86904735001335, this batch provides consistent dosage for research studies.

Note: this product is solely for experimental research use and not for therapeutic or diagnostic use in humans or animals.

Product Specifications

Mechanism of Action & Research Applications

Methylprednisolone binds to glucocorticoid receptors, modulating gene expression to suppress inflammatory cytokines and immune cell activation. In research, it is applied to:

• Inflammatory disease modeling (e.g. rheumatoid arthritis, lupus)

• Immunomodulation and cytokine regulation studies

• Endocrine and adrenal function assays

• Pharmacokinetic and glucocorticoid receptor response evaluation

Its high receptor affinity and predictable pharmacokinetics make it suitable for precise dosing experiments.

Side Effects (For Reference Only in Models)

In laboratory or animal studies, potential effects may include:

• Suppression of immune cell function

• Altered blood glucose and lipid profiles

• Hypertension, fluid retention

• HPA axis suppression with repeated dosing

• Osteopenia or bone metabolism changes

These observations are included for experimental planning and safety context only.

Disclaimer

This product is intended strictly for laboratory research use only and is not approved for human or veterinary use. Researchers must comply with institutional safety protocols and applicable regulations.